trial · primary record
ATV-1601
Hereditary Hemorrhagic Telangiectasia (HHT)
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2030-03 |
| Primary endpoint | Part 1: Safety and tolerability |
| Registry ID | NCT07601425 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:35.905Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07601425
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.